Retrospective Safety Survey of Selected Events in the 6 Months Following the 4th Dose of the Pentacel Vaccination Series in Children.

Trial Profile

Retrospective Safety Survey of Selected Events in the 6 Months Following the 4th Dose of the Pentacel Vaccination Series in Children.

Completed
Phase of Trial: Phase IV

Latest Information Update: 10 Apr 2014

At a glance

  • Drugs Hib-DTaP-poliovirus vaccine (Primary)
  • Indications Diphtheria; Haemophilus infections; Pertussis; Poliomyelitis; Tetanus
  • Focus Adverse reactions
  • Sponsors Sanofi; sanofi pasteur
  • Most Recent Events

    • 08 Apr 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top